catalyst
as of 2026-07-01A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Pa — primary completion
at a glance
2025-06-25 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Pa — primary completion
Type
Trial Readout
Date
2025-06-25
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here